5-Amino-1MQ is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose
Best within 36 months after opening
The growing understanding of AD as a multifactorial disease necessitates an approach that simultaneously addresses tau pathology, neuroinflammation, oxidative stress, mitochondrial dysfunction, and synaptic loss (Chu et al., 2024)
How is care delivered
Although its tumoricidal properties hold therapeutic promise, its clinical application in lower gastrointestinal diseases and cancers remains challenging
(270) reported a patient in whom clinical, laboratory and histologic features of autoimmune hepatitis developed after beginning MEL therapy for the treatment of insomnia